title: Management of lipid abnormalities in patients on CAPD.
authors.forename: E V
authors.initials: EV
authors.lastname: Balaskas
authors.forename: G I
authors.initials: GI
authors.lastname: Bamihas
authors.forename: A
authors.initials: A
authors.lastname: Tourkantonis
mesh_terms: D018752:Diet, Fat-Restricted; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D050356:Lipid Metabolism; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D017035:Pravastatin / Q000627:therapeutic use
chemical_list: D015525:Fatty Acids, Omega-3; D000960:Hypolipidemic Agents; D017035:Pravastatin; D015248:Gemfibrozil